Bradley A.  Alford net worth and biography

Bradley Alford Biography and Net Worth

Director of Perrigo
Bradley A. Alford has been a director of Perrigo since February 2017. Mr. Alford joined Advent International Corporation, a global private equity firm, in 2014 as an Industry Advisor and moved to Operating Partner in March of 2016. From 2006 to 2013, Mr. Alford was Chairman and Chief Executive Officer of Nestlé USA. Mr. Alford also served as CEO and President of Nestlé Brands Company. He currently serves as a director of Avery Dennison Corporation since April 2010 and previously served as a director of Conagra Brands, Inc. from July 2015 to September 2018. Throughout his career, Mr. Alford has been focused on developing brands, initiatives to improve processes and facilitate best practices across an organization.

What is Bradley A. Alford's net worth?

The estimated net worth of Bradley A. Alford is at least $678,002.78 as of June 5th, 2020. Mr. Alford owns 24,154 shares of Perrigo stock worth more than $678,003 as of November 23rd. This net worth estimate does not reflect any other assets that Mr. Alford may own. Learn More about Bradley A. Alford's net worth.

How do I contact Bradley A. Alford?

The corporate mailing address for Mr. Alford and other Perrigo executives is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. Perrigo can also be reached via phone at (531) 709-4000 and via email at [email protected]. Learn More on Bradley A. Alford's contact information.

Has Bradley A. Alford been buying or selling shares of Perrigo?

Bradley A. Alford has not been actively trading shares of Perrigo over the course of the past ninety days. Most recently, on Thursday, December 16th, Bradley A. Alford bought 13,000 shares of Perrigo stock. The stock was acquired at an average cost of $36.88 per share, with a total value of $479,440.00. Learn More on Bradley A. Alford's trading history.

Who are Perrigo's active insiders?

Perrigo's insider roster includes Bradley Alford (Director), Svend Andersen (EVP), Eduardo Bezerra (CFO), Rolf Classon (Director), James Dillard, III (EVP), Thomas Farrington (EVP), Alison Ives (EVP), Ronald Janish (EVP), Murray Kessler (CEO), Todd Kingma (VP), Patrick Lockwood-Taylor (President, CEO & Director), Geoffrey Parker (Director), Grainne Quinn (EVP), Theodore Samuels, II (Director), Raymond Silcock (CFO), Richard Sorota (EVP), and Robert Willis (EVP). Learn More on Perrigo's active insiders.

Are insiders buying or selling shares of Perrigo?

During the last twelve months, Perrigo insiders bought shares 5 times. They purchased a total of 24,540 shares worth more than $675,232.90. During the last twelve months, insiders at the sold shares 3 times. They sold a total of 50,254 shares worth more than $1,411,969.20. The most recent insider tranaction occured on September, 13th when Director Katherine C Doyle sold 8,954 shares worth more than $244,444.20. Insiders at Perrigo own 0.7% of the company. Learn More about insider trades at Perrigo.

Information on this page was last updated on 9/13/2024.

Bradley A. Alford Insider Trading History at Perrigo

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/16/2021Buy13,000$36.88$479,440.00View SEC Filing Icon  
See Full Table

Bradley A. Alford Buying and Selling Activity at Perrigo

This chart shows Bradley A Alford's buying and selling at Perrigo by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Perrigo Company Overview

Perrigo logo
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Read More

Today's Range

Now: $28.07
Low: $26.96
High: $28.12

50 Day Range

MA: $25.98
Low: $24.18
High: $28.21

2 Week Range

Now: $28.07
Low: $23.89
High: $34.60

Volume

1,408,270 shs

Average Volume

1,624,318 shs

Market Capitalization

$3.83 billion

P/E Ratio

N/A

Dividend Yield

4.07%

Beta

0.48